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ABSTRACT 
Although transdermal route of drug delivery displays numerous benefits over conventional strategies, this pathway is yet to presents its 
complete potential. The chief ground for this statement is ascribed to the presence of extremely packed outermost layer of skin called stratum 
corneum. This compactly packed barrier is selectively permeable and furnishes smaller and lipophilic molecules to diffuse into the deeper skin 
layers. Due to this only a few transdermal product is commercially available. So in order to guarantee the effective transport of drug molecules, 
it is necessary to break the stratum corneum layer. There are two acceptable methods to break the stratum corneum architecture- active 
strategy which comprises the application of external energy such as in electroporation, sonophoresis, iontophoresis etc. and passive strategy 
which involve the application of permeation enhancers, nanoparticles etc. This article comprehensively detail the active and passive methods 
employed in transdermal drug delivery systems to disrupt the stratum corneum bilayers.  
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Introduction 
Transdermal route of drug transport provides fascinating 
non-invasive approach compared to conventional strategies 
such as intravenous injection and oral routes. The chief 
benefit of transdermal strategy is the absence of first pass 
hepatic metabolism. In addition, transdermal route furnishes 
sustained delivery of therapeutic entities, ease of patch 
application, avoids the requirement of trained staff to 
administer drug, patch can be swiftly removed in the case of 
toxicity 1.  
The conventionally used transdermal devices allow 
controlled delivery, but are employed to small lipophilic 
drug molecules ascribed to the barrier properties of the 
outermost layer of skin called stratum corneum (SC) 2. The 
chief lipids present in the SC include fatty acids, wax esters, 
ceramides, cholesterol etc. Ceramides are the chief lipid 
groups and are pivotal to the organization of lipid 
architecture. The barrier behavior of SC is due to the lipid 
bilayers present in the intercellular spaces 1. The permeation 
of skin can be improved by three main mechanisms such as 
by reorganizing physicochemical behavior of SC, by altering 
hydrating behavior of SC and by changing structures of 
proteins and lipids in the intercellular channels 3.  
The progress of skin permeation enhancement approaches is 
likely to play a remarkable role in the development of 
transdermal pathway. Several skin permeation enhancement 
strategies have been introduced and studied to efficiently 
transport therapeutic entities across the skin. Reaearchers 
reported the so called passive and active approaches to 
enhance the permeation of both hydrophilic and lipophilic 
molecules across the skin 2.  
Strategies to overcome skin barrier function 
The poor permeability of mammalian skin ascribed to the 
compactly packed SC is the main hurdle in TD drug delivery. 
The principle challenges in TD research is to break the skin 
barrier properties. Over the last decades, there has been a 
significant interest in developing skin permeation 
enhancement techniques. Presently there are numerous 
enhancement techniques that can be employed to optimize 
TD drug delivery (Fig. 1). 
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Fig. 1. Different approaches to overcome skin barrier function 
1. Passive penetration enhancement strategies 
The skin penetration mechanism in passive TD system is 
completely based on the diffusion of the therapeutic entities 
across the SC layers. Latest approaches which are presently 
under research ranging from chemical penetration 
enhancers which breaks the SC barrier function by 
intensifying the drug diffusion across the SC layers or 
improving the solubility of drugs in the skin to advanced 
strategies, which comprises the magnification of this idea to 
the development of nanoparticles, inclusion complexes, 
vesicle formulations etc. 
1.1. Microemulsions 
Microemulsions are stable and clear dispersion comprising 
of oil, surfactant and aqueous phase, commonly in 
combination with a co-surfactant. Recently microemulsions 
have been widely investigated in TD applications due to 
their thermodynamic stability, easy and inexpensive 
preparation, increased bioavailability, small droplet size and 
high solubilization capacity for both lipophilic and 
hydrophilic drug molecules 4.  
The frequently studied skin penetration enhancers that have 
been employed as oil phase of TD microemulsion are 
saturated and unsaturated fatty acids. Aungst and coworkers 
investigated the TD delivery of naloxone using several 
vehicles such as fatty acids, sulfoxides, alcohol etc and 
revealed that the vehicles with an unsaturated C10-C12 and a 
polar head and vehicles with C18 alkyl group like oleic acid, 
observed to be the optimal formulations. Compared to trans 
configuration, the unsaturated cis configuration can 
effectively disturb the compactly packed SC lipid layers 5. 
Due to the hydrophobic nature of SC layers, the fatty acid can 
effectively interact with lipid bilayers and disturb it by 
producing separate domains which ultimately enhances skin 
permeability 6. On the other hand surfactants such as 
phospholipids, polysorbates, azones, polyglycerol fatty acid 
esters, dioctyl sodium sulphosuccinate etc can effectively 
perturb SC layers. It is necessary to stress that water is used 
as aqueous phase in most of the formulations 4. The skin 
permeation profile of microemulsons is remarkably higher 
upon compared to conventional formulations such as creams 
and losions.  
1.2. Vesicles 
Vesicles function as both drug carrier to transport 
encapsulated drug across the SC layers and skin penetration 
enhancer to break barrier function. Liposomes and niosomes 
are the vesicular platforms which have acquired ample 
attention to facilitate TD drug delivery. Literature stated that 
in certain cases liposomes and niosomes are retained in the 
upper layer of SC and cannot penetrate into deeper skin 
layers to obtain desired therapeutic effect 7.  
Transferosomes are a unique class of liposomes, comprising 
of phosphatidylcholine and an edge activator and possess 
significant elasticity compared to conventinal liposomes. It 
can encapsulate therapeutic entities with different range of 
solubility as they contains both hydrophilic and hydrophobic 
moities. They bypass the SC layer by squeezing themselves 
along the intercellular sealing lipids of SC 8. Furthermore 
transferosomes are biocompatinle, non-toxic and possess 
high encapsulation efficiency. Kong et al prepared HA 
modified trnsferosomes to transport doxorubicin across the 
skin and reported that the device could potentially penetrate 
into deeper skin layers, furnishing a new perspective for 
tumor metastatis therapy 9. Ethosomes are another 
catergory of vesicles prepared from phospholipids, ethanol 
and water, which provide remarkably higher TD flux 
compared to liposomes. Ethanol present in ethosomes 
function as a penetration enhancer and transport drug 
across intercellular lipids 10.  
1.3. Eutectic mixtures 
Eutectic mixture is a combination of two or more 
components which normally do not combine to form a new 
compound; however which at particular ratios give a system 
with lower melting point than the components mixed. 
Literature disclosed that the melting point of a drug is 
inversely related to its lipophilicity and solubility in lipids. 
Hence lowering of melting point of drugs by the formation of 
an eutectic mixture increases its lipid solubility and finally 
enhances TD flux 11.  
The eutectic mixture enhances the TD flux by two discrete 
mechanisms. One is the development of a low melting 
mixture with the therapeutic entity which enhances its 
partition across the SC layers. Other is the direct 
perturbation of SC architecture which additionally improves 
the skin permeability 12. Yuan et al remarkably lowered the 
melting point of ibuprofen and ketoprofen by eutectic 
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mixture formation in presence of aqueous isopropyl alcohol 
and enhanced their skin permeability 13. The research group 
of Barry prepared eutectic mixtures between ibuprofen and 
seven terpenes including thymol, cineol etc. They found that 
the TD flux of ibuprofen across the skin from the eutectic 
system was significantly higher compared to saturated 
aqueous solution 14.  
1.4. Inclusion complexes 
Inclusion complex is a species in which one compound called 
the “host” possess an internal cavity into which another 
compound the “guest” can seat. The distinct architecture of 
βCD with a hydrophobic cavity and a hydrophilic exterior 
surface permits the formation of inclusion complex. Modified 
βCD is an interesting TD drug delivery platform as they 
enhance the skin permeability by two mechanistic pathways. 
βCD improves the solubility of drug molecules, producing a 
greater driving force for piercing SC layers. The interaction 
of βCD with lipid bilayers also breaks skin barrier 
properties. In addition to furnishing exceptional 
permeability, βCD complexation significantly reduces the 
drug induced irritation 15. Felton et al reported that 
hydroxypropyl-βCD remarkably enhanced the aqueous 
solubility of oxybenzone and improved its skin permeability 
16. Avobenzone- hydroxypropyl-βCD complexation  was 
reported by Yang et al and skin permeability studies 
revealed that the TD flux enhanced with increasing the 
concentration of hydroxypropyl-βCD 17.  
1.5. Nanoparticles 
In the last few decades nanoparticles have been widely 
studied for several pharmaceutical applications as they 
furnish sustained drug release, enhance the stability of drug 
molecules by physical or chemical means and offer targeted 
therapy 18. Interestingly nanoparticles have gained 
significant attention as TD carriers due to their ability to 
penetrate skin layers as a function of size, surface charge 
and shape. It is regarded that nanoparticles pierce the skin 
by three routes:- intercellular pathway through corneocytes, 
intercellular routes through lipids or dermal architecture  
such as hair follicles 19.  
The most widely employed nanoparticles for TD applications 
include metal nanoparticles, polymeric nanoparticles, nano-
emulsions, dendrimers etc 18. Natural polymeric 
nanoparticles such as CS, alginic acid and albumin 
nanoparticles have been widely investigated as TD drug 
delivery platform. Nevertheless natural polymers are 
replaced by synthetic polymers to furnish high purity and 
consistent drug release pattern. Sheihet et al prepared ABA 
triblock polymer nanospheres from polyethylene glycol, 
suberic acid and desaminotyrocyl-tyrosine alkyl ethers. In 
vitro permeation test disclosed that these nanospheres 
delivered model drug molecules nine times more to deeper 
skin layers compared to reference device 20.  
Dendrimers are complex molecules which have been 
extensively used to develop TD formulations ascribed to its 
nanometric size and narrow polydispersity. Priyanka et al in 
a review stated that dendrimers are employed for the TD 
delivery of non-steroidal anti-inflammatory, antimicrobial, 
antihypertensive and anticancer drugs 21. Dendrimers 
enhance the TD flux by temporarily perturbing the skin 
layers to furnish a diffusion pathway for penetrating 
molecules. Furthermore its globular shape enhances its 
capacity to break barrier functions than linear shaped 
molecules 22. The investigation of Hong’s group revealed that 
poly(amidoamine) dendrimers produces nanosized 
openings on lipid bilayers as a result of strong lipid-
dendrimer interaction 23.  
Metallic nanoparticles such as gold nanoparticle (GNP), 
silver nanoparticle, titanium nanotube (TNT) etc received 
ample attention in TD drug delivery due to their substantial 
effect on local penetration in SC layers. Tak et al studied the 
shape dependent skin penetration behavior of silver 
nanoparticles. In vivo skin permeation studies have shown 
that rod shaped nanoparticles demonstrated the highest skin 
permeability followed by spherical and triangular 
nanoparticles. These outcomes indicated that the 
intercellular pathway plays a significant role in enhancing 
the skin permeability and not the follicular route 24. 
In addition to the detailed strategies skin permeability can 
also be enhanced using super loaded formulations, 
coacervation effect etc 12. An efficient method to enhance TD 
flux is by enhancing the concentration of dissolved drugs 
without causing any damage to skin tissue. In coacervation 
techniques oppositely charged species forms pair, 
dissociates in epidermis and releasing the parent molecules 
25. Efforts are in progress to fabricate potential TD platforms 
that provide sufficient therapeutic efficiency without 
generating any health issues.  
2. Active penetration enhancement strategies 
2.1. Iontophoresis 
TD iontophoresis is a needleless approach in which a small 
electric current is used to transport therapeutic entities 
across the skin. It is a programmable system in which the 
rate of transport of drug molecules could be controlled by 
the fine-tuning of the applied electric current. In this 
technique only a feable current below 500 µA/cm2 of skin is 
applied to avoid pain, burn and irritation caused by the 
application of electric current. Iontophoresis enhances the 
skin permeability by distinct mechanisms such as 
electroosmosis, electrophoresis and increasing the skin 
porosity 26.  
Nevertheless the potential of iontophoresis to improve the 
TD flux of non-polar drugs is unsatisfactory due to the 
absence of charge and poor solubility in water 27. The 
passive TD strategy of proteins and peptides is less efficient 
as they are charged at physiological pH. However 
iontophoresis significantly enhances the TD flux of charged 
species 28. Literature stated that charged species generally 
select the pathway of least electrical resistance in the skin 
and the route is assumed to be the sweat glands or hair 
follicles 29. In iontophoresis the anionic drugs are place 
under cathode and cationic drugs under anode. When a 
feable electric current is supplied, the drugs are repelled into 
the skin and finally penetrates through different skin layers 
to reach the systemic distribution. Furthermore 
iontophoresis has been employed for the TD delivery of 
steroids, anaesthetics, retenoids, anti-inflammatory drugs 
etc.  
2.2. Microneedles 
TD microneedle patches have been substantially 
investigated in the last few years due to their ease of 
application, high drug loading, painless administration and 
potential drug delivery. The fabrication of microneedle 
should be in such a way that the needle possess sufficient 
length to pierce into the dermis, but should be narrow to 
prevent the stimulation of dermal nerves. Microneedle 
therapy remarkably improves the penetration of drug 
molecules across the skin. When applied on skin, the narrow 
needle can efficiently puncture the SC layers and a portion of 
the epidermis, producing micron-sized holes which promote 
the delivery of drug molecules to dermal micro circulation.  
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The substances employed to fabricate micronnedles are 
silicon, polymers and metals. Hollow microneedle array is a 
special type of patch that permits the TD transport of drug 
molecules across the skin via the injection of the 
formulations through the adhered hollow device. Coated 
microneedle is another TD patch fabricated by coating solid 
microneedle with a formulation of drug before inserting into 
skin surface. The coated microneedle patches heve been 
used for the TD delivery of several molecules including 
proteins, DNA and peptides 30. Dissolving microneedles are 
intersting catergory of TD device. The water soluble 
polymeric microneedles prepared from PVA, gelatin, HA, 
poly(vinyl pyrrolidone) and carboxymethylcellulose when 
applied on skin, they swiftly dissolve upon exposure with 
water and hence avoids the danger of needles staying in the 
skin. The fabrication of microneedle patches presently faces 
certain issues including the harsh processing conditions, 
which restricts the category of drugs that can be employed. 
Furthermore, the application of microneedle patches 
produce microscopic holes, which sometimes results in 
bacterial infections. There are still milestones to be acquired 
to develop a more patient friendly microneedle patch with 
controlled drug delivery 31.  
2.3. Sonophoresis 
The ultrasound mediated TD drug delivery at frequencies in 
the range of 20 KHz – 16 MHz and intensity upto 14 W/cm2 
is referred as sonophoresis. The TD flux is remarkably 
higher at low frquency range (20-100 kHz) than at high 
frequency 32. The skin penetration enhancement effect  of 
ultrasound is described by two mechanisms- thermal effect 
and cavitational effects. When skin is treated with 
ultrasound, the absorption of energy results in local 
temperature increase which results in enhanced skin 
permeability. The research group of Gay evaluated the role 
of ultrasound frequency on the TD delivery of mannitol and 
found that the application of low frequency ultrasound (20 
KHz) increased the temperature by around 20 0C and 
enhance the TD flux by approximately 35 fold. However they 
also reported that the enhancement effect is also ascibed to 
another mechanism called cavitation 33. Cavitation means 
the generation of cavities and disruption of pre-existing gas 
bubbles in a liquid medium. The violent growth and collapse 
of bubbles upon ultrasound propagation produces shock 
waves, which creates structural changes in SC layers. This 
alteration of SC architecture generates channels for the facile 
diffusion of drug molecules 34. The size and cost of the 
ultrasound equipments is the principal challenge in the 
sonophoresis. Furthermore the safety of ultrasound 
application should be throughly investigated through further 
research. 
2.4. Electroporation 
Electroporation refers to the temporary disruption of SC 
layers and further enhancement in TD drug delivery 
following the influence of electric pulse. It has been used for 
the efficient TD transportation of drugs like metroprolol and 
fentanyl, macromolecules like heparin, oligonucleotides and 
peptides. Enhancement in electroporation mediated TD 
delivery between one and four order of magnitudes have 
been acquired, depending on the size and solubility of drugs 
and strength of the applied voltage pulses.  
The important characteristics of electroporation consists 
enhanced TD flux for a variety of drug molecules, quick 
responsive TD delivery and modulation of delivery by 
regulating the physicochemical behavior of reservoir and 
electrical parameters 35. Several strategies have been 
employed to evaluate the skin tolerance of electroporation. 
Ultrastructural investigation and clinical tests revealed that 
the overall alteration of the skin architecture upon skin 
electroporation are gentle and reversible 35. 
2.5. Other approaches 
Pressure wave produced by intense laser radiation is one of 
the recent strategy which can enhance the skin permeability. 
The pressure wave only permeabilizes the SC layer and the 
transport of therapeutic entities occur by diffusion under the 
concentration gradient through the channels created by the 
pressure waves 36. Magnetic field have also been used to 
overcome the skin barrier properties. Literature stated that 
magnetic field enhanced the TD delivery of drug molecules 
including terbutaline sulfate, salbutamol sulfate etc 
37(Murthy et al., 2010). The investigation of Krishnan and 
coworkers disclosed that the TD drug delivery was enhanced 
by the application of electromagnetic field of 5.0 mT and is 
ascribed to the modulation of SC permeability 38. Needleless 
injector is an attractive TD drug delivery platform which 
offer less pain than hypodermal injection. This technique is 
used for the delivery of peptides and proteins across the skin 
39.  
Conclusions 
In this article the passive and active methods to vanquish the 
SC layers are detailed. Passive strategies such as 
microemulsions, vesicles, eutetic mixtures, inclusion 
complex and nanoparticle displays excellent potential to 
enhance the transport of therapeutic entities across the skin. 
Active strategies includes iontophoresis, microneedles, 
sonophoresis and electroporation, could effectively disrupt 
lipid layers of skin and facilitates the transport of drug 
molecules. This article could assist researchers to 
accelerates  the  development of transdermal products. 
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